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Abstract
Objective: Platelet-rich plasma (PRP) is considered to enhance bone formation especially at early stages of wound 
healing, depending on the limited and short life-span of platelets and growth factors. The aim of this study was to 
evaluate efficacy of double-application of PRP (DA-PRP) on bone healing in a rabbit calvarial defect model. 
Study design: Twenty-eight rabbits, each had two surgically prepared calvarial bone defects (10mm diameter), 
were included in this study and randomly divided into six groups. Defects (n=56) were treated with single-ap-
plication of PRP (SA-PRP)(n=10), SA-PRP and beta-tricalciumphosphate (SA-PRP+TCP)(n=10), DA-PRP (n=8), 
DA-PRP and beta-tricalciumphosphate (DA-PRP+TCP)(n=8), beta-tricalciumphosphate (TCP)(n=10) or left emp-
ty (Control)(n=10). Animals were sacrificed at 30 days postoperatively. 
Results: The new bone (NB%) and defect fill (DF%) percentages were calculated from histological slides by 
image-analyzer software and statistically analysed. All test groups showed higher NB% than control, but differ-
ences among all groups were insignificant. The TCP treated groups had significantly higher DF% than groups 
treated without TCP, however the DF% differences between control, SA-PRP and DA-PRP or TCP, SA-PRP+TCP 
or DA-PRP+TCP were insignificant. 
Conclusion: Although new bone formation was histomorphologically remarkable at double-application PRP 
groups, statistical analyses of the histomorphometric data revealed no significant difference.
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Introduction
Lately, platelet rich plasma (PRP), an autologous platelet 
concentration, suggested to have a potential to increase 
regeneration and accelerate wound healing, due to the 
various growth factors it consists (1-4). PRP applica-
tion, previously, has been showed to increase the local 
platelet concentration by 338% (5) and consequently in-
crease the local growth factor concentration(6). Platelet 
derived growth factor, transforming growth factor-beta, 
insulin like growth factor, endothelial growth factor, fi-
broblast growth factor and vascular endothelial growth 
factor are some of the growth factors described in PRP 
(5,7,8). Combination of two or more growth factors are 
already known to be more effective on many cell types 
compared to single growth factors (9). There are numer-
ous encouraging reports in the favour of PRP (1,10,11), 
however PRP is still a terra incognita in many terms. 
It remains a question that how long PRP is effective. Re-
garding short life-span of platelets and platelet derived 
growth factors, PRP is believed to be effective predomi-
nantly at the early stages of the hard tissue healing.(5,12) 
Degradation of platelets and growth factor release re-
ported to be at first 3-5 days and therefore growth fac-
tor activity is suggested to be at first 7-10 days.(12) It 
was also suggested that direct effects of platelet derived 
growth factors start to disappear gradually after 5-6 
days.(5) Also, it is still unknown that how many times 
PRP should be applied to the wound area or do multiple 
applications improve the results. 
Crovetti et al. (2004) treated 24 cutaneous chronic non-
responsive severe ulcers with multi-application of PRP 
topically and reported 9 to be healed completely and 8 
healed >50% (13). Driver et al. (2006) compared multi 
application of PRP gel with saline gel (control) topical 
dressing in the treatment of nonhealing diabetic foot ul-
cers (14). They reported that treated wounds healed sig-
nificantly more in PRP gel group (13 out of 16, 81.3%) 
than in control group (eight out of 19, 42.1%) (P = 0.036) 
(14). Radaelli et al. evaluated the outcomes, benefits and 
side effects of a standardized PRP injection protocol in a 
series of 23 consecutively treated patients and reported 
that results were promising for face and neck revitaliza-
tion (15). More recently Kon et al. (2010) evaluated ef-
ficacy of PRP at the treatment of degenerative lesions of 
articular cartilage of knee after multi intra-articular PRP 
injections and their preliminary results indicated that 
treatment with PRP injections was safe and has the po-
tential to reduce pain and improve knee function (16). 
Considering the limitations of autogenous bone and al-
lografts, such as limited availability of donor sites and 
enhanced risk of disease transmission, respectively, al-
loplastic grafts appears to be safe and convenient (17-21). 
Beta-tricalcium phosphate (b-TCP), which has intercon-
nected system of micropores, Ca/PO4 ratio similar to a 
natural bone and approximately 12 months of resorption 
time in human intrabony defects, has been widely used 
as a biologically safe osteoconductive alloplastic bone 
substitute (1,22-24). The clinical and experimental stud-
ies examining the effects of PRP and b-TCP together 
reported that both b-TCP alone and PRP/b-TCP were 
successful at the treatment of intrabony defects, howe-
ver those studies had conflictive conclusions about ad-
ditional effects of PRP: Some of the authors reported 
that PRP had significantly improved the results achieved 
by b-TCP alone (10,11,25), whereas others claimed that 
PRP had no additional benefits to b-TCP treatment at 
intrabony defects (19,26). 
Although numerous studies evaluated single applica-
tion of PRP and/or graft-PRP combinations at the treat-
ment of intrabony defects (3,7,10,27), there is still lack 
of information on efficacy of multi-application of PRP 
on osseous defects. Within the limitations of our know-
ledge, the present study appears to be the first study to 
examine double-application of PRP alone and together 
with b-TCP in the treatment of bone defects. 
The purpose of the present study was to evaluate efficacy 
of double-application of PRP (DA-PRP) on bone healing 
in a rabbit cranial defect model, alone and in combination 
with b-TCP, and to compare it with single-application of 
PRP and empty controls by histological methods. 
Materials and Methods
Twenty-eight healthy 6-months-old female New Zea-
land rabbits weighing between 3-4 kg were used as 
experimental animals for the study. Before the study, 
general health of the rabbits was monitored for 10 days. 
The rabbits were kept in standard cages in an experi-
mental animal room and were fed a standard laboratory 
diet and water. This study protocol was approved by the 
ethical committee for animal experiments of the Gazi 
University, Ankara, Turkey (G.Ü.ET-06.043).
-PRP Preparation 
Sterile disposable monovette system (Curasan, Pharma 
Gmbh AG, Lindigstrab, Germany ) and compatible cen-
trifuge machine (Heraeus Labofuge 300, Kendro Labo-
ratory Products, D-37520 Osterrade, German ) was used 
for preparations of PRP. 
Eight ml of peripheral blood was drawn from each ani-
mal by venipuncture and transferred into red marked 
monovette containing 0.5 ml citrate (10% trisodium 
citrate), approximately 30 min before the surgery. 
Monovette is centrifuged at 2400 rpm for 10 min. Af-
ter the first centrifugation, two layers were seen clearly 
in the monovette. Previously it was reported that upper 
yellow layer was consist of platelet rich and poor plas-
ma and lower red layer was consist of erythrocytes and 
leukocytes.(2) And also lower red layer’s top 1-2 mm 
part was reported to be rich from platelets which newly 
joined to the circulation.(3,4) A total of 4 mm plasma, 
which consisted of complete upper yellow layer and also 
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lower red layer’s top 1-2 mm part, transferred into a yel-
low marked monovette. After the second centrifugation 
at 3600 rpm for 15 min, approximately 0.7 mm was 
plasma rich from platelets at bottom of the monovette 
and the upper rest was plasma poor from platelet.(2) 
Part of the platelet poor plasma was collected and dis-
carded. Remaining 0.7 ml plasma at the bottom of the 
yellow marked monovette vortexed for 20 sec and trans-
ferred into green marked application injector. This final 
preparation of PRP (2,28) was ready to use. 
-Surgical Procedure
All surgical procedures were performed under aseptic 
conditions in an animal-operating suite at Gazi Uni-
versity. The rabbits were anaesthetized with an intra-
muscular dose of 35mg/kg ketamine (Ketanes, Alke, 
İstanbul, Turkey) and 5mg/kg xylazine (Rompun, Bayer, 
Leverkusen, Germany). Animals were placed in sterna 
recumbency. Their head was shaved and the cutaneous 
surface was disinfected with a povidone iodine solution 
prior to surgery. The calvaria bone was exposed after 
incision of skin and periosteum, respectively. Two cir-
cular calvarial bone defects (0,5mm thick x 10mm inner 
diameter) were made in parietal bone, on each side of 
the median sagittal suture without crossing it, using a 
trephine bar on a slow-speed electric hand piece by ap-
plying physiologic saline irrigation without injuring the 
underlying duramater.
The rabbits were randomly divided into six groups and 
cranial defects (n=56) were treated with single-applica-
tion of PRP (SA-PRP) (n=10), SA-PRP and beta-trical-
ciumphosphate (β-TCP) graft (SA-PRP+TCP) (n=10), 
DA-PRP (n=8), DA-PRP and β-TCP (DA-PRP+TCP) 
(n=8), β-TCP (TCP) (n=10) or left empty (control) (n=10). 
Study design was summarized at (Fig. 1).
PRP was prepared before the operations, as described 
above, at all PRP groups on Day-0 of the study. Regard-
ing PRP applications for SA-PRP and DA-PRP groups, 
final PRP preparation was mixed with autogenous 
blood taken from defect area for activation of platelets, 
approximately 5 min prior to application to the defect 
area. As for preparation of PRP+TCP combinations for 
SA-PRP+TCP and DA-PRP+TCP groups, β-TCP (Cera-
sorbÒ, pure β-TCP granules, 0.5gr, granule size 500-
1000µm, Curasan, Kleinostheim, Germany) was trans-
ferred into sterile glass godet then blood taken from 
defect site and PRP were added and mixed. PRP/β-TCP 
combination was ready for application after approxi-
mately 5 min. The skin was relocated with silk continu-
ous sutures (3/0) following the closure of periosteum 
with resorbable (4/0) sutures (Pegesorb, Doğsan, Trab-
zon, Turkey ). Post-operative analgesics were adminis-
tered as intramuscular ketoprofen (Profenid, Eczacıbaşı, 
İstanbul, Turkey ) 3mg/kg 1x1 for 3 days. 
Second PRP preparation for DA-PRP and DA-PRP+TCP 
groups took place at Day-15, which was transferred to the 
same defect areas via injection. The animals were sacri-
ficed 4 weeks after the initial intervention with an intra-
venous overdose of a combination of ketamine and xyla-
zine. The calvarium bone including defect and surround-
ing bone was dissected and placed into the 10% formalin 
buffer solution at pH 7.0 before further analysis. Samples 
transferred to the laboratory for histological examination.
Fig. 1. Study design.
-Histological evaluation 
All histological procedures and evaluations were car-
ried out at the Department of Oral Pathology, Faculty 
of Dentistry, Gazi University. Hard tissue samples were 
fixed with 10% buffered formalin for 24–72 hours and 
decalcified with 10% formic acid for 3 weeks. After 
washing under tap water overnight, samples were em-
bedded in paraffin. Three sections with 4µm thickness 
were cut at the central region of each specimen to ob-
tain maximum standardization of the cutting surface. 
All sections were deparaffinised at 56oC and by xylene 
then incubated in absolute and 96% ethanol. For his-
tomorphological evaluation, sections were stained with 
routine hematoxylene-eosine (H&E). 
All histological evaluations of stained sections were 
carried out using Leica DM 4000 B microscope (Leica 
Microsystems GmbH. Wetzlar, Germany) and Leica 
QWin Plus v3.3.1 image analyzer programme (Leica 
Microsystems GmbH. Wetzlar, Germany). The follow-
ing measurements were taken from each histological 
central section: dimensions of total defect area, newly 
formed bone and remaining graft material areas. These 
data permit to calculate defect fill (DF %) and new bone 
percentages (NB %):
New Bone (NB%) = New bone area / Total defect area 
x 100
Defect Fill (DF%) = New bone area + remaining area of 
graft materials / Total defect area x 100
-Statistical analysis
Statistical analysis was performed by Statistical Pack-
age for Social Sciences (SPSS) 11.5 software (SPSS Inc., 
Chicago, IL, United States ). Whether the continuous 
variables were normally distributed or not was deter-
mined by using Shapiro Wilk test. Data were expressed 
as median and (25th – 75th) percentiles. Differences 
among six groups regarding for continuous date were 
evaluated by Kruskal-Wallis variance analysis. When 
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the p-value from the Kruskal-Wallis test statistics is 
statistically significant, Conover’s multiple comparison 
test was used to know which groups differ from which 
others.(29) A p value less than 0.05 was considered as 
statistically significant. 
Results
In all groups, different percentage of connective tissue, 
new bone formation, and graft particles were seen in 
defected areas. All groups except for control sections 
showed bone formation throughout the bone defect. 
Light microscope photographs of haematoxylin & eosin-
stained sections from each group are shown in Figures 
2 to 7. In control group, minimal amount of new bone 
formation and chronic inflammatory infiltrate on fibrous 
connective tissue were seen (Fig. 2). In SA-PRP and DA-
PRP groups, cellular new bone formation on vascularised 
connective tissue ground was observed (Figs. 3,4). In 
TCP, SA-PRP+TCP, and DA-PRP+TCP groups, fibrous 
connective tissue filled around granular graft material 
and in their neighbourhood cellular, new bone forma-
tion in close connection with granules was seen (Figs. 
5-7). No foreign body reaction or osteoclast activity was 
detected. Lamellar bone formation in especially DA-
PRP+TCP group indicated matured new bone. 
Histomorphometric results for NB % and DF % were 
summarized at (Figs. 8-10). Minimum-maximum va-
lues as well as 50th (median), 25th and 75th percentiles 
are shown at (Figs 8,9). 
The highest NB % was calculated in defects of TCP 
group, followed by SA-PRP+TCP, DA-PRP+TCP, DA-
PRP, SA-PRP and Control groups, respectively (Fig. 8). 
The NB % differences among groups were not statisti-
cally significant. 
The each of the three groups treated with TCP, regard-
less of any PRP application addition, showed signifi-
cantly more DF% than DA-PRP, SA-PRP and Control 
groups (p<0,001) (Fig. 9). 
Fig. 2. Light microscope photograph of a section from 
Control group. The inflamed connective tissues (ICT) are 
seen (H&E × 100).  
Fig. 3. Light microscope photograph of a section from SA-
PRP group. The cellular new bone (NB) are seen (H&E 
× 100). 
Fig. 5. Light microscope photograph of a section from TCP 
group. The new bone (NB) can be seen around graft mate-
rial (G) (H&E × 100).  
Fig. 4. Light microscope photograph of a section from 
DA-PRP group. The new bone (NB) can be seen over the 
fibrous connective tissue (FCT) ground (H&E × 100).  
Med Oral Patol Oral Cir Bucal. 2012 Jan 1;17 (1):e171-7.                                                                                                                                                                                Double-application of PRP
e175
Fig. 6. Light microscope photograph of a section from SA-
PRP+TCP group. The photograph shows new bone (NB) 
around graft material granules (G) (H&E × 100).
Fig. 7. Light microscope photograph of a from DA-
PRP+TCP group. The graft granules (G) are surrounded 
by cellular and lamellar new bone (NB) (H&E × 100).
Fig. 8. Minimum-maximum values and 50th (me-
dian), 25th and 75th percentiles of New Bone (%) 
for the study groups.
Fig. 9. Minimum-maximum values and 50th (me-
dian), 25th and 75th percentiles of Defect fill (%) 
for the study groups. * The difference between 
Control group (p<0,001). † The difference between 
SA-PRP group (p<0,001). ‡ The difference be-
tween DA-PRP group (p<0,001).
Discussion
In the present study we evaluated the effect of double 
application of PRP on bone healing in a rabbit calvarial 
defect model.
For this purpose, we created two circular bone defects 
with 10 mm diameter on each rabbit calvaria. Previ-
ously, the critical size for rabbit calvarial bone defects 
was described as 15 mm in diameter (30). However, it 
is also known that creating multiple critical size bone 
defects on rabbit calvaria is not always possible due to 
the small size of rabbit calvaria (27). Kroese-Deutman 
et al. compared healing of rabbit calvarial bone defects 
with 6, 9 and 15 mm diameters and concluded that de-
fect diameter did not affect on new bone percentage at 
the defect area (31). 
In accordance with the previous reports (32,33), we found 
that addition of PRP to b-TCP granules made manipula-
tion of graft granules easier and enhanced graft stabiliza-
tion along with immobilization of graft in the defect area. 
Histomorphometric data of the present study suggested 
that all treatment modalities were successful at the treat-
ment of rabbit calvarial bone defect. Each resulted with 
more new bone formation than empty control group at 
the end of the one month; however no statistically sig-
nificant difference was detected among groups. 
Aghaloo et al. (27) evaluated PRP application alone and 
compared with empty controls in a rabbit non-critical 
size cranial defect model at first, second and fourth 
months after surgery. They reported that defects treated 
with PRP did not showed significant advantages over 
controls either with histological or radiographical exa-
mination (27). Furthermore, Miloro et al. (34) stated that 
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addition of PRP alone did not provide any statistically 
significant benefit to healing in an osteotomized defect 
of rabbit mandible at first, second and third months af-
ter surgery. On the other hand, Fontana et al. (35) exa-
mined osteogenesis around titanium implants placed at 
rat tibia with or without PRP and reported significantly 
more new bone formation at sites treated with PRP after 
four weeks. Mariano et al. (36) histologically analyzed 
the influence of PRP on bone healing in surgically crea-
ted critical-size defects in the calvaria of diabetic rats at 
the end of a month and found that PRP significantly en-
hanced bone healing both qualitatively and quantitative-
ly. The conflictive results of the different studies about 
treatment with PRP alone may be due to different defect 
models, as well as different evaluation techniques and 
periods. The present data showed that PRP alone did not 
add significant benefits to the wound healing at the end 
of the first month, when compared to empty controls 
and any other treatments evaluated. 
In our study, prosperous new bone formation and sig-
nificantly higher defect fill was observed more in the 
groups treated with b-TCP. Yazawa et al. (10) reported 
considerably more new bone formation at the rabbit cal-
varial and mandibular intrabony defects treated with 
both TCP and PRP from the first day to first, fourth and 
eighth weeks. Kovacs et al. (1) evaluated healing at bea-
gle dog bilateral mandibular defects treated with either 
TCP or PRP/TCP combination at sixth and 12th weeks. 
They reported that at post-op sixth week rounded TCP 
granules were surrounded by a fibrous encapsulations at 
TCP groups, where as TCP granules were surrounded 
by cell-rich mesencymal tissues at PRP/TCP group (1). 
Connective tissue islands and osteoid bridging were de-
scribed as characteristics in the pores of the granules, 
as a major difference from group treated TCP alone (1). 
Intragranular budding of the richly capillarised osteo-
genic mesenchyma and osteoid bridges were reported to 
be more visible in the pores of the granules of PRP/TCP 
treated group at 12th week (1). When new bone forma-
tion was quantified with histomorphometric procedures, 
authors declared that no significant difference was de-
tected between the groups at six weeks, whereas signifi-
cantly more new bone formation was detected in PRP/
TCP group compared to TCP group (1). Moreover, in a 
similar study model, with the histomorphometric evi-
dences authors suggested that the newly formed bone at 
12th week with PRP/TCP treated defects had the similar 
quality with autogenous bone (11). In the present study, 
no significant differences were detected between TCP, 
SA-PRP+TCP and DA-PRP+TCP groups at the end of 
the one month from the stand point of new bone for-
mation or defect fill. When current data considered to-
gether with the results of the previous studies, we think 
that evaluating longer monitoring periods together with 
the results of first month healing may add different as-
pects to the evaluation of double application of PRP. Al-
though the PRP is believed to be effective mainly at the 
early stages of the hard tissue healing, more evidence is 
needed to understand the extents of this effect and the 
most appropriate time of evaluation. 
Previously, some promising results of multi applica-
tion of PRP via injection (15,16) or topically application 
(13,14) for face and neck rejuvenation, scar attenuation, 
treatment of chronic diabetic ulcers and degenerative 
lesions of articular cartilage of the knee was reported in 
medicine. To our knowledge, present study appears to 
be the first one to examine the influence of double-ap-
plication of PRP in experimental bone healing model. 
In the present study, it was histomorphologically ob-
served that newly formed bone trabeculae in double-
application of PRP groups were also more mature and 
lamellar than both control and single-application PRP 
groups either with or without TCP. In particular, less 
osteocyts per unit tissue and less lamellar lining was 
detected within new bone trabeculae of control group, 
which both emphasized the limited maturation of bone. 
The histomorphological analyses revealed a remarkable 
increase in new bone formation with the addition of 
double-application of PRP. All histomorphometric ana-
lyses were carried out with an image analyse software 
programme which allow us to have quantitative results 
in addition to our histomorphological observations. Al-
though our histomorphological findings were in favour 
of double-application of PRP, statistical analyses of the 
quantitative data did not revealed a significant increase 
in defect fill or new bone formation with the addition of 
double-application of PRP. Furthermore, in the present 
study the sample size was small, consisting of 8 to 10 
defects in each group, which may have contributed to 
the lack of statistical significance between groups. 
We think that more evidences are required for the better 
understanding of potential of double-application of PRP 
at the treatment of intrabony defects. Although it is well 
known that animals have different regeneration capabil-
ity from humans (37) and experimental studies do not 
give the same results as human clinical studies, still we 
think that current findings can form the starting point of 
further clinical human research in the future. Further stu-
dies conducted with longer evaluation intervals for newly 
formed bone and defect fill, as well as studies evaluating 
immunohistochemical markers of bone formation within 
postoperative first month are needed to clarify the addi-
tional effects of double application of PRP.
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